MAPVIEW

Serial Number 98190510
Registration 7733678
700

Registration Progress

Application Filed
Sep 21, 2023
Under Examination
Aug 20, 2024
Approved for Publication
Jun 25, 2024
Published for Opposition
Jun 25, 2024
Registered
Mar 18, 2025

Trademark Image

MAPVIEW

Basic Information

Serial Number
98190510
Registration Number
7733678
Filing Date
September 21, 2023
Registration Date
March 18, 2025
Published for Opposition
June 25, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 18, 2025
Registration
Registered
Classes
035 042

Rights Holder

Komodo Health, Inc.

03
Address
680 Folsom Street, 5th Floor
San Francisco, CA 94107

Ownership History

Komodo Health, Inc.

Original Applicant
03
San Francisco, CA

Komodo Health, Inc.

Owner at Publication
03
San Francisco, CA

Komodo Health, Inc.

Original Registrant
03
San Francisco, CA

Legal Representation

Attorney
Jordan A. LaVine

USPTO Deadlines

Next Deadline
1890 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250318)
Due Date
March 18, 2031
Grace Period Ends
September 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Mar 18, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 24, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 24, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 21, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 11, 2024 IUAF S USE AMENDMENT FILED Loading...
Feb 21, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 11, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 20, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 25, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 25, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 5, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 22, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 22, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 22, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 22, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 22, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 14, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 14, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 14, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 14, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 1, 2023 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Nov 1, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Oct 8, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 25, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; business consulting and analysis services regarding information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; Providing business information in the field of the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies; Business consulting services to businesses in the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies
First Use Anywhere: Mar 19, 2024
First Use in Commerce: Mar 19, 2024
Class 042
Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare viewing of a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs, all of the foregoing excluding psychedelic medicines and therapies; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (paas) featuring computer software platforms that allow the viewing of market access insights to the life sciences industry, provide business solutions that unify pharmaceutical sales, operations, and marketing data, and provide data intelligence that aids with effective targeting, messaging, and initiatives driving sales performance, all of the foregoing excluding psychedelic medicines and therapies; Design, development and implementation of computer software for the healthcare and life sciences industry, namely, the design and development of cloud-based and application-based software for monitoring, marketing, and delivering products in the healthcare and life sciences industry, all of the foregoing excluding psychedelic medicines and therapies; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Business technology software consultation services in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Software development and product development consulting in the field of the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies
First Use Anywhere: Mar 19, 2024
First Use in Commerce: Mar 19, 2024

Additional Information

Pseudo Mark
MAP VIEW

Classification

International Classes
035 042